Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Ipamorelin was first described in the mid-1990s and belongs to the class of compounds known as growth hormone secretagogues (GHS) molecules that interact with the ghrelin/GHS receptor
30 mL) and is intended for intramuscular or intravenous administration by healthcare professionals
10.1210/jc.2009-1503 26 Delgado-ArosS.KimD.-Y.BurtonD
Newer options like retatrutide show even more promise in clinical trials
Gastrointestinal adverse effects, initially viewed as limiting, were ultimately managed through dose titration and formulation design
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
